As early and effective antiretroviral therapy has become more widespread, HIV has
transitioned from a progressive, fatal disease to a chronic, manageable disease marked by …

Epicardial adipose tissue has unique properties that distinguish it from other depots of
visceral fat. Rather than having distinct boundaries, the epicardium shares an unobstructed …

Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF)
remains a challenge. We recommend a new stepwise diagnostic process, the 'HFA–PEFF …

Antiretroviral therapy has largely transformed HIV infection into a chronic disease condition.
As such, physicians and other providers caring for individuals living with HIV infection need …

Background People living with HIV (PLWH) experience higher risk of myocardial infarction
(MI) and heart failure (HF) compared with uninfected individuals. Risk of other …

HIV-related cardiovascular disease research is predominantly from Europe and North
America. Of the estimated 37· 9 million people living with HIV worldwide, 25· 6 million live in …

In 2015, the United Nations set important targets to reduce premature cardiovascular
disease (CVD) deaths by 33% by 2030. Africa disproportionately bears the brunt of CVD …

Background The incidence of sudden cardiac death and sudden death caused by
arrhythmia, as determined by autopsy, in persons with human immunodeficiency virus (HIV) …

According to statistics from the World Health Organization,≈ 36.7 million people are
currently living with HIV, and 1.8 million become infected every year. Antiretroviral therapy …

Background: Incident heart failure (HF) is increased in persons with human
immunodeficiency virus (PHIV). Protease inhibitors (PIs) are associated with adverse …